Bloomios sets stage for stronger growth, expands production capacity by 300%

Stock Information for Bloomios Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Bloomios Inc

Bloomios Reports Q2 2023 Financial Results
Bloomios Appoints Kevin Henry as National Sales Director
Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million
Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer
Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
Upexi Announces Sale of Select CBD Assets for $23.5 Million
Bloomios To Present at The 2022 LD Micro Main Event October 25-27
Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.